Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species
study of tissue expression profiles, polymorphisms of HPSE (show HPSE ELISA Kits) and HPSE2 genes and changes of their mRNA levels in porcine alveolar macrophages (PAMs) induced by PRRSV; upon stimulation in healthy piglets with PRRSV, HPSE (show HPSE ELISA Kits) mRNA was obviously upregulated, while HPSE2 mRNA did not induce a prominent change in PAMs
our results suggest that heparanase 2 functions as a tumor suppressor in bladder cancer
we provide evidence that Hpa2 overexpression in head and neck cancer cells markedly reduces tumor growth
The most common HPA (show HPSE ELISA Kits) genotypes among Saudis were HPA-1 (show HPSE ELISA Kits) a + b- (75%), HPA-2 a + b- (62%), HPA-3 a + b- (51.5%), HPA (show HPSE ELISA Kits)-4 a + b- (99%), HPA-5 (show ITGA2 ELISA Kits) a + b- (76.5%), HPA (show HPSE ELISA Kits)-6 a + b- (100%) and HPA (show HPSE ELISA Kits)-15 a + b + (50%). The prevalent allele among the HPA (show HPSE ELISA Kits) systems was (a), except in the HPA (show HPSE ELISA Kits)-15 system where the (b) allele was found in 52% of the subjects.
HPSE2 mutations were found in one Urofacial syndrome family but not detected in patients with non-neurogenic neurogenic bladder and severe lower urinary tract dysfunction
Heparanase 2 is more intensely expressed in the glandular tissue of cancer than in nonneoplastic endometrium; the HPSE2 expression in the stromal tissue is higher in the nonneoplastic controls compared with cancer mainly in the secretory endometrium.
High expression of heparanase-2 is associated significantly with gastric tumor growth and differentiation
Data indicate that the overexpression of HPSE1 (show HPSE ELISA Kits) and HPSE2 in the intervertebral degenerated discs suggests a role for these factors in mediating extracellular matrix remodeling in degenerative discs during disease development.
HPSE2 c.631T>C (p.Y211H) is a novel benign SNP and c.1628A>T (p.N543I) is the disease-causing mutation in urofacial syndrome.
Studies indicate that cathepsin L (show CTSL1 ELISA Kits) as the heparanase (show HPSE ELISA Kits) activating protease.
These results indicate a regulatory effect of heparanase (show HPSE ELISA Kits) on TFPI (show TFPI ELISA Kits) and TFPI-2 (show TFPI2 ELISA Kits) in trophoblasts, suggesting a potential involvement of heparanase (show HPSE ELISA Kits) in early miscarriages.
Deletion of Hpse2 cause the urofacial syndrome-like phenotype in mice.
This gene encodes a heparanase enzyme. The encoded protein is a endoglycosidase that degrades heparin sulfate proteoglycans located on the extracellular matrix and cell surface. This protein may be involved in biological processes involving remodeling of the extracellular matrix including angiogenesis and tumor progression. Alternate splicing results in multiple transcript variants.
, heparanase 3
, heparanase-like protein
, inactive heparanase-2